ERBA ups its product portfolio at ARAB Health 2014
25.03.2014 / BioSpectrum
The ERBA Group of Companies has spread its wings across the globe and is today recognized as one of the most reputed organizations offering quality diagnostic solutions. Innovative products, ably supported by an excellent after sales service, has made ERBA a trusted partner for innumerable healthcare professionals throughout the world. Transasia Bio-Medicals Ltd. is a subsidiary of the global ERBA Group of companies.
The Arab Health Exhibition and Congress offers a global platform for the confluence of some of the best names in the industry. This year Arab Health was held in January 2014 at the Dubai International Convention and Exhibition Centre. More than 3900 exhibitors and representatives from over 153 countries made the convention a grand success.
ERBA has been an active part of the exhibition for ten years. This year too, the ERBA Group showcased some of its latest and best technologies in the field of Clinical Chemistry, Hematology, Critical Care, Diabetes, Immunology, Urine Analysis, Hemostasis and Microbiology.
The key highlight at the event was the launch of ERBA’s latest biochemistry analyzer XL 180 and diabetes management analyzer Hb Vario. The ERBA Group was well represented by Suresh Vazirani, chairman & managing director and the team from ERBA Group.
More than 1000 people including reputed pathologists, microbiologists, diabetologists & hematologists from all over the world, visited the ERBA stall. Some of the famous names include the Ministry Of Health (MOH) team from UAE, Saudi Arabia, Kuwait & Oman. They highly appreciated ERBA Group’s technical expertise.